Glucose Monitoring Device Market Size, Share, Analysis Report

Glucose Monitoring Device Market By Product (Diabetes monitoring devices, Insulin delivery devices); By Application (Hospitals, Personal use) and by Regional Analysis - Global Forecast by

The Glucose Monitoring Device Market is expected to be around US$ 7.50 Billion by 2028 at a CAGR of 6% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Roche
  • DexCom
  • Johnson & Johnson
  • AstraZeneca
  • Insulet
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    6

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    The growing incidence of diabetes and rising awareness about the self-administration of diabetes is filling the development of the global glucose monitoring devices market. The presentation of therapeutic gadgets that are perfect with cell phones and shrewd devices is putting forth simple access to these gadgets to an expansive number of end-clients in the global market. The incorporation glucose monitoring devices with mobile applications has facilitated the monitoring of blood glucose levels among patients.

    How Big is The Glucose Monitoring Device Market?

    The Glucose Monitoring Device Market is expected to be around US$ 7.50 Billion by 2028 at a CAGR of 6% in the given forecast period.

    The major driving factors of Glucose Monitoring Device Market are as follows:

    • R&D and increasing technological innovations
    • Growing prevalence of diabetes on a global level
    • Rise in demand for point of care testing (POCT)

    The major restraining factors of Glucose Monitoring Device Market are as follows:

    • Stringent rules for glucose monitoring devices
    • Standardisation and unfavourable reimbursement policies

    The major opportunities of Glucose Monitoring Device Market are as follows:

    • Improvements in the self-monitoring blood glucose (SMBG) devices
    • Growth of emerging economies

    The Glucose Monitoring Device Market has been segmented as below:

    By Product:

    By Application:

    • Hospitals
    • Personal use

    By Regional Analysis:

    •     North America
    •     Europe
    •     Asia-Pacific
    •     Rest of the World

    The Glucose Monitoring Device Market is segmented on the lines of its technology, component, vehicle type and regional. On the basis of product segmentation it includes Diabetes monitoring devices and Insulin delivery devices. Based on application classification it covers Hospitals and Personal use. The Glucose Monitoring Device Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    This report provides:

    1) An overview of the global market for Glucose Monitoring Device Market and related technologies.
    2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
    3) Identifications of new market opportunities and targeted promotional plans for Glucose Monitoring Device Market

    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry. 

    Report scope:

    The scope of the report includes a detailed study of Glucose Monitoring Device Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche, DexCom, Johnson & Johnson, AstraZeneca, Insulet, Sanofi, Merck, GSK, Nova Biomedical, Becton Dickinson, Eli Lilly, Lupin, Braun, Takeda Pharmaceutical, Bayer HealthCare, Abbott Diabetes Care, Boehringer Ingelheim, Novo Nordisk, GlySens, Senseonics, Novartis, Omron Healthcare, Philips Healthcare, GE Healthcare, Medtronic and ResMed. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

    Reasons to Buy this Report:

    1. Obtain the most up to date information available on all Glucose Monitoring Device Market.
    2. Identify growth segments and opportunities in the industry.
    3. Facilitate decision making on the basis of strong historic and forecast of Glucose Monitoring Device Market.
    4. Assess your competitor’s refining portfolio and its evolution.

    Customization:

    We can offer you custom research reports as per client’s special requirements.

    Below are our new reports:

    Glucose Biosensor Market

    General Surgery Devices Market

    Gastrointestinal Endoscopic Devices Market

    Gastrointestinal (GI) Stents Market

    1.    Introduction
        1.1    Report Description
        1.2    Markets Covered
        1.3    Stakeholders

    2.    Research Methodology
        2.1    Research Data
        2.2    Market Size Estimation and Data Triangulation
        2.3    Research Assumptions

    3.    Report Summary

    4.    Market Overview
        4.1    Introduction
        4.2    Drivers
        4.3    Restrains
        4.4    Industry Trends
        4.5    Porter’s Five Forces Analysis

    5.    Glucose Monitoring Device Market Analysis, By Product
        5.1    Diabetes monitoring devices
        5.2    Insulin delivery devices

    6.    Glucose Monitoring Device Market Analysis, By Application
        6.1    Hospitals
        6.2    Personal use

    7.    Glucose Monitoring Device Market Analysis, By Region
        7.1    North America
        7.2    Europe
        7.3    Asia-Pacific
        7.4    Rest of the World

    8.    Competitive Overview
        8.1    Introduction
        8.2    New Product Launches
        8.3    Acquisitions
        8.4    Agreements, Partnerships, And Collaborations
        8.5    Expansions

    9.    Company Profiles
        9.1    Roche
        9.2    DexCom
        9.3    Johnson & Johnson
        9.4    GSK
        9.5    Nova Biomedical
        9.6    Becton Dickinson
        9.7    Eli Lilly
        9.8    Merck
        9.9    Takeda Pharmaceutical
        9.10    Bayer HealthCare
        9.11    Abbott Diabetes Care
        9.12    Boehringer Ingelheim
        9.13    Insulet
        9.14    Sanofi
        9.15    Novo Nordisk
        9.16    GlySens
        9.17    Senseonics
        9.18    Braun
        9.19    AstraZeneca
        9.20    Omron Healthcare
        9.21    Philips Healthcare
        9.22    GE Healthcare
        9.23    Medtronic
        9.24    ResMed
        9.25    Novartis
        9.26    Lupin

    The Glucose Monitoring Device Market has been segmented as below:

    By Product:

    • Diabetes monitoring devices
    • Insulin delivery devices

    By Application:

    • Hospitals
    • Personal use

    By Regional Analysis:

    •     North America
    •     Europe
    •     Asia-Pacific
    •     Rest of the World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 6% during the study period (2023-2028)
    The Glucose Monitoring Device Market is expected to be around US$ 7.50 Billion by 2028
    The segment included in Glucose Monitoring Device Market is Product, Application and region.
    Some key players operating in the Glucose Monitoring Device Market include Roche, DexCom, Johnson & Johnson, AstraZeneca, Insulet, Sanofi, Merck, GSK, Nova Biomedical, Becton Dickinson, Eli Lilly, Lupin, Braun
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports